CollPlant Biotechnologies Ltd. (CLGN)

NASDAQ: CLGN · Real-Time Price · USD

2.550

-0.100 (-3.77%)

At close: Mar 28, 2025, 4:00 PM

2.695

+0.145 (5.70%)

Pre-market: Mar 31, 2025, 7:01 AM EDT

CollPlant Biotechnologies Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019 - 2015
Revenue	0.52	10.96	0.3	15.64	6.14	Upgrade
Revenue Growth (YoY)	-95.30%	3565.22%	-98.09%	154.86%	164.75%	Upgrade
Cost of Revenue	1.63	1.99	0.4	2.01	3	Upgrade
Gross Profit	-1.11	8.97	-0.1	13.64	3.14	Upgrade
Selling, General & Admin	5.63	6	6.74	5.94	4.67	Upgrade
Research & Development	10.52	10.48	10.26	7.63	4.07	Upgrade
Operating Expenses	16.14	16.48	17	13.57	8.73	Upgrade
Operating Income	-17.25	-7.51	-17.1	0.07	-5.6	Upgrade
Interest Expense	-	-	-0.02	-0.01	-0.02	Upgrade
Interest & Investment Income	0.74	0.79	0.32	0.22	-	Upgrade
Currency Exchange Gain (Loss)	-0.08	-0.29	-0.12	-0.04	-0.18	Upgrade
Other Non Operating Income (Expenses)	-0.02	-0.01	-0.01	-0	0.03	Upgrade
Pretax Income	-16.61	-7.02	-16.93	0.24	-5.77	Upgrade
Net Income	-16.61	-7.02	-16.93	0.24	-5.77	Upgrade
Net Income to Common	-16.61	-7.02	-16.93	0.24	-5.77	Upgrade
Shares Outstanding (Basic)	11	11	11	10	7	Upgrade
Shares Outstanding (Diluted)	11	11	11	12	7	Upgrade
Shares Change (YoY)	0.57%	3.23%	-7.80%	73.76%	38.12%	Upgrade
EPS (Basic)	-1.45	-0.62	-1.53	0.02	-0.84	Upgrade
EPS (Diluted)	-1.45	-0.62	-1.53	0.02	-0.84	Upgrade
Free Cash Flow	-14.58	-3.72	-14.97	1.07	-4.89	Upgrade
Free Cash Flow Per Share	-1.27	-0.33	-1.36	0.09	-0.71	Upgrade
Gross Margin	-215.53%	81.83%	-33.78%	87.18%	51.08%	Upgrade
Operating Margin	-3349.71%	-68.55%	-5718.06%	0.42%	-91.23%	Upgrade
Profit Margin	-3225.05%	-64.05%	-5660.53%	1.52%	-94.08%	Upgrade
Free Cash Flow Margin	-2830.29%	-33.92%	-5007.36%	6.86%	-79.65%	Upgrade
EBITDA	-16.21	-6.41	-16.02	0.84	-4.94	Upgrade
EBITDA Margin	-	-58.49%	-	5.36%	-80.48%	Upgrade
D&A For EBITDA	1.04	1.1	1.08	0.77	0.66	Upgrade
EBIT	-17.25	-7.51	-17.1	0.07	-5.6	Upgrade
EBIT Margin	-	-68.55%	-	0.42%	-91.23%	Upgrade

Updated Nov 27, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q